PEGFILGRASTIM-JMDB for Malignant connective tissue neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where PEGFILGRASTIM-JMDB was used for Malignant connective tissue neoplasm.
Most Reported Side Effects for PEGFILGRASTIM-JMDB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 51 | 17.0% | 50 | 1 |
| Product quality issue | 21 | 7.0% | 0 | 0 |
| Drug ineffective | 20 | 6.7% | 3 | 12 |
| Device leakage | 17 | 5.7% | 0 | 0 |
| Hospitalisation | 15 | 5.0% | 1 | 14 |
| Needle issue | 14 | 4.7% | 0 | 0 |
| Neutropenia | 13 | 4.3% | 2 | 7 |
| Febrile neutropenia | 12 | 4.0% | 1 | 6 |
| Nausea | 11 | 3.7% | 1 | 5 |
| Off label use | 11 | 3.7% | 0 | 0 |
| Device issue | 10 | 3.3% | 0 | 0 |
| Vomiting | 10 | 3.3% | 1 | 8 |
| Pyrexia | 9 | 3.0% | 1 | 7 |
| Device breakage | 8 | 2.7% | 0 | 0 |
| Device defective | 8 | 2.7% | 2 | 2 |
Other Indications for PEGFILGRASTIM-JMDB
Product used for unknown indication (128)
Neutropenia (22)
Febrile neutropenia (12)
Agranulocytosis (10)
Chemotherapy (9)
Prophylaxis (9)
Breast cancer (7)
Neoplasm malignant (7)
Ovarian cancer (6)
Diffuse large b-cell lymphoma (5)
Other Drugs Used for Malignant connective tissue neoplasm
PAZOPANIB (417)
CABOZANTINIB S-MALATE (188)
RIPRETINIB (139)
IMATINIB (80)
AVAPRITINIB (73)
TAZEMETOSTAT HYDROBROMIDE (72)
NIVOLUMAB (60)
PALBOCICLIB (50)
SUNITINIB MALATE (39)
IPILIMUMAB (24)